TTS Pharma Limited (TTS), a vertically integrated supply chain manager in the cultivation, manufacturing, and development of the emerging ethical cannabis market, announces that it has successfully closed a private placement totalling £10.3 million.
This investment will support TTS in becoming one of the leading global suppliers in this fast-growing industry, allowing it to expand its existing supply chain, develop its own facilities and further strengthen its academic and commercial partnerships.
Crowe has supported TTS during this period of growth, with corporate finance partner Mitesh Patelia leading the team, assisted by Alex Nursey.
“Crowe has been an extremely trusted advisor during this exciting period of growth. We would recommend them to any emerging company that require the skillset of a full service accountancy firm."
Mark Tucker, CEO, TTS Pharma Limited